Literature DB >> 19796447

Modelling the impact of varicella vaccination on varicella and zoster.

M Karhunen1, T Leino, H Salo, I Davidkin, T Kilpi, K Auranen.   

Abstract

It has been suggested that the incidence of herpes zoster may increase due to lack of natural boosting under large-scale vaccination with the varicella vaccine. To study the possibility and magnitude of such negative consequences of mass vaccination, we built a mathematical model of varicella and zoster epidemiology in the Finnish population. The model was based on serological data on varicella infection, case-notification data on zoster, and new knowledge about close contacts relevant to transmission of infection. According to the analysis, a childhood programme against varicella will increase the incidence of zoster by one to more than two thirds in the next 50 years. This will be due to increase in case numbers in the 35 years age groups. However, high vaccine coverage and a two-dose programme will be very effective in stopping varicella transmission in the population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796447     DOI: 10.1017/S0950268809990768

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Varicella vaccination programs do not seem to shift the age of disease to older age groups.

Authors:  Manuel García Cenoz
Journal:  Transl Pediatr       Date:  2014-10

2.  The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.

Authors:  Giorgio Guzzetta; Piero Poletti; Stefano Merler; Piero Manfredi
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

3.  Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study.

Authors:  Ahmet Soysal; Erdem Gönüllü; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

4.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

5.  Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.

Authors:  Monica Betta; Marco Laurino; Andrea Pugliese; Giorgio Guzzetta; Alberto Landi; Piero Manfredi
Journal:  Proc Biol Sci       Date:  2016-03-16       Impact factor: 5.349

Review 6.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

7.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

8.  Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Authors:  Johannes Horn; André Karch; Oliver Damm; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; Hartmut Hengel; Wolfgang Greiner; Rafael T Mikolajczyk
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

9.  The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.

Authors:  Valentina Marziano; Piero Poletti; Giorgio Guzzetta; Marco Ajelli; Piero Manfredi; Stefano Merler
Journal:  Proc Biol Sci       Date:  2015-04-07       Impact factor: 5.349

10.  Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.

Authors:  Piero Poletti; Alessia Melegaro; Marco Ajelli; Emanuele Del Fava; Giorgio Guzzetta; Luca Faustini; Giampaolo Scalia Tomba; Pierluigi Lopalco; Caterina Rizzo; Stefano Merler; Piero Manfredi
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.